APOBEC3G 抗体 (C-Term)
-
- 抗原 See all APOBEC3G 抗体
- APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
-
抗原表位
- C-Term
-
适用
- 人
-
宿主
- 山羊
-
克隆类型
- 多克隆
-
标记
- This APOBEC3G antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 特异性
- This antibody reacts to APOBEC3G.
- 纯化方法
- Affinity chromatography
- 免疫原
- Peptide with sequence C-DEHSQDLSGRLR, from the C Terminus of the protein sequence
- Top Product
- Discover our top product APOBEC3G Primary Antibody
-
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (AA 60-330) antibody
APOBEC3G 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (AA 60-330) antibodyAPOBEC3G 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (C-Term) antibodyVerified APOBEC3G 适用: 人 WB, ELISA, IHC 宿主: 山羊 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (AA 51-100) antibodyAPOBEC3G 适用: 人 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (N-Term) antibodyAPOBEC3G 适用: 人, Pig WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (AA 1-384) antibodyAPOBEC3G 适用: 人 ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) antibodyAPOBEC3G 适用: 人, 大鼠 IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (C-Term) antibodyAPOBEC3G 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (AA 191-384) antibodyAPOBEC3G 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) antibodyAPOBEC3G 适用: 人, 大鼠 WB, IHC, IF, IC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
Peptide ELISA: 1/16000. Western Blot: 0.5 - 1.5 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - 限制
- 仅限研究用
-
- 浓度
- 0,5 mg/mL
- 缓冲液
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freezing and thawing.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- 抗原
- APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
- 别名
- APOBEC3G (APOBEC3G 产品)
- 别名
- A3G antibody, ARCD antibody, ARP-9 antibody, ARP9 antibody, CEM-15 antibody, CEM15 antibody, bK150C2.7 antibody, dJ494G10.1 antibody, apolipoprotein B mRNA editing enzyme catalytic subunit 3G antibody, APOBEC3G antibody
- 背景
- APOBEC3G is a DNA deaminase (cytidine deaminase) that mediates a form of innate resistance to retroviral infections (at least to HIV1 infection) by triggering G-to-A hypermutation in the newly synthetized viral DNA. The replacements C-to-U in the minus strand DNA of HIV1 during reverse transcription, leads to G-to-A transitions in the plus strand. The inhibition of viral replication is either due to the degradation of the minus strand before its integration or to the lethality of the hypermutations. Modification of both DNA strands is not excluded. This antiviral activity is neutralized by the virion infectivity factor (VIF), that prevents the incorporation of APOBEC3G into progeny HIV1 virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome. APOBEC3G binds a variety of RNAs, but does not display detectable APOB, NF1 and NAT1 mRNA editing. APOBEC3G is involved in hepatitis B virus (HBV) resistance probably primarily by inhibiting viral pregenomic RNA packaging. This activity is independent of the cytidine deaminase activity, as the inactivated protein is able to inhibit HBV replication. During HBV infection, APOBEC3G does not seem to be involved in the editing of HBV DNA, but this might occur in particular cellular contexts or with specific viral strains. APOBEC3G is a homodimer. It interacts with APOBEC3B, APOBEC3F and HIV1 VIF in a species specific manner. It is expressed in spleen, testes, ovary and peripheral blood leukocytes and CD4+ lymphocytes. Also expressed in non permissive peripheral blood mononuclear cells, and several tumor cell lines, no expression detected in permissive lymphoid and non-lymphoid cell lines. Normally not expressed in the liver, but it is possible that it is induced in the course of HBV infection, for instance under the influence of cytokines. APOBEC3G is ubiquitinated in the presence of HIV1 VIF. Association with VIF targets the protein for proteolysis by the ubiquitin dependent proteasome pathway. APOBEC3G inhibits also the infectivity of retroviral particles only distantly related to HIV1, such as the simian immunodeficiency virus (SIV), the equine infectious anemia virus (EIAV) and the murine leukemia virus (MLV).Synonyms: APOBEC-3G, APOBEC-related cytidine deaminase, ARCD, ARP9, CEM15, DNA dC->dU-editing enzyme APOBEC-3G, MDS019
- 基因ID
- 60489, 9606
- UniProt
- Q9HC16
-
